Why the study?
Does Telmisartan reduce blood pressure, cardiac hypertrophy, and renal damage in spontaneously hypertensive rats compared to Losartan, Captopril, or no treatment?
Population
Four months old male spontaneously hypertensive rats of the stroke prone strain (SHRsp)
Comparison
Telmisartan orally at high dose or low dose for… vs Losartan, Captopril, or untreated control
Design
Preclinical
Follow-up
38 days
Authors
Loading...
May suggest ARB-specific anti-hypertrophic effects beyond BP reduction in rats; leaves open clinical translation and requires human trials.
Does Telmisartan reduce blood pressure, cardiac hypertrophy, and renal damage in spontaneously hypertensive rats compared to Losartan, Captopril, or no treatment?
Telmisartan provides comparable blood pressure lowering and renoprotection to other AT1 receptor antagonists or ACE inhibitors, but demonstrates a unique and marked reduction in cardiac hypertrophy in a hypertensive rat model.
Wagner et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: